Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 7/10/23 → 7/10/25 |
Funding
- Legend Biotech USA Incorporated: $312,473.00
23-LUN-133-LB-PMC: LB2102-1001, A First in Human Dose Escalation and Cohort Expansion Study of DLL3-directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
- Hao, Zhonglin (PI)